BioMark Diagnostics, Inc. (BUX.CX)
BioMark Diagnostics Market Cap: 51.49M for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Justera Health Ltd. | 0.5024M |
| Neural Therapeutics, Inc. | 3.374M |
| ARCpoint, Inc. | 1.925M |
| Biocure Technology, Inc. | 0.8083M |
| Core One Labs, Inc. | 6.829M |
Market Cap Related Metrics
| PS Ratio | 402.87 |
| Price to Book Value | 59.61 |
| Price | 0.49 |
| Earnings Yield | -3.33% |